The global breast imaging market is poised for significant growth, with sales projected to rise at a 6.5% CAGR between 2024 ...

The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer ...

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

Megan Shellhorn, local mom, breast cancer survivor founds Pink Lights the Way to help patients find support DOGE ...

CEO transition Teri Thomas, who has led Volpara since 2022, played a key role in the company's transformation, strengthening its AI platform and overseeing its 2024 acquisition by Lunit. Under her ...

Researchers at the Arc Institute, Stanford University, and NVIDIA have developed Evo 2, an advanced AI model capable of ...

Breast cancer is the second leading malignant disease in females worldwide. Over decades of research, breast cancer classification by molecular subtypes has ...